US Broker Ratings

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Promising Biotech with Nearly 24% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company headquartered in London, is capturing investor interest with its innovative approach to drug development and a promising upside potential of nearly..

Centene Corporation (CNC) Investor Outlook: Navigating a Healthcare Giant Amidst Mixed Analyst Ratings

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $19.01 billion, the company continues to..

Amgen Inc. (AMGN) Stock Analysis: Robust Revenue Growth and Attractive Dividend Yield Captivate Investors

Amgen Inc. (Nasdaq: AMGN), a stalwart in the healthcare sector and a leading player in the drug manufacturing industry, continues to capture investor interest with its robust financial performance and..

Fresenius Medical Care AG (FMS) Investor Outlook: Exploring a Potential 11.55% Upside in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS) stands as a global leader in the healthcare sector, specializing in providing essential dialysis and related services for individuals with renal diseases. With a..

UnitedHealth Group (UNH) Stock Analysis: Navigating a Healthcare Giant with a $326B Market Cap

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable titan in the healthcare sector, commanding a market capitalization of $326.22 billion. As the largest healthcare company in the United States..

Insulet Corporation (PODD) Stock Analysis: Unpacking the 17% Upside Amid Robust Revenue Growth

Insulet Corporation (NASDAQ: PODD), a pioneering entity in the healthcare sector, specializes in medical devices, specifically insulin delivery systems. With a market capitalization of $21.76 billion, Insulet stands as a..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Growth Potential Amidst a $8.22 Billion Market Cap

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, has carved a niche in the medical devices industry. Headquartered in Hercules, California, Bio-Rad operates globally, offering life..

Elanco Animal Health (ELAN) Stock Analysis: Strong Buy Ratings Amidst Revenue Growth and Strategic Positioning

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a pivotal player in the healthcare sector, specifically within the drug manufacturing industry that caters to both specialty and generic needs. Headquartered..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 15% Potential Upside with Strategic Segment Innovations

Solventum Corporation (SOLV), a significant player in the healthcare sector, is drawing investor attention with its diverse portfolio and a promising potential upside of 15.02% as indicated by recent analyst..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.25% Potential Upside in the Healthcare Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, continues to draw investor attention with its robust portfolio and a potential upside of 9.25%. Headquartered in Melville, New..

Natera, Inc. (NTRA) Stock Analysis: Unveiling Growth Potential Amidst Strong Buy Ratings

Natera, Inc. (NASDAQ: NTRA) is capturing investor attention in the healthcare sector with a market capitalization of $22.98 billion. Specializing in diagnostics and research, the company offers an array of..

Baxter International Inc. (BAX) Stock Analysis: Navigating the Healthcare Giant’s 23.50% Potential Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, offers a broad spectrum of medical instruments and supplies, catering to diverse markets ranging from hospitals to home healthcare...

Viatris Inc. (VTRS) Investor Outlook: Navigating a 12.15% Potential Upside Amidst Healthcare Challenges

Viatris Inc. (NASDAQ: VTRS), a formidable player in the healthcare sector, operates across a vast array of global markets, delivering a diverse portfolio of prescription brand drugs, generic drugs, and..

Chemed Corp (CHE) Stock Analysis: Unlocking a Potential Upside of Over 30% in the Healthcare Sector

Chemed Corp (NYSE: CHE) stands out as a formidable player in the healthcare and medical care facilities sector, primarily operating in the United States. With a market capitalization of $6.46..

CVS Health Corporation (CVS) Stock Analysis: A Strong Buy with a 6.47% Upside and Robust Growth Potential

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, continues to cement its position as a leader in healthcare plans and services in the United States. With a..

GSK plc (GSK) Stock Analysis: Navigating the Healthcare Giant’s 3.77% Dividend Yield Amidst Market Challenges

GSK plc (GSK), a stalwart in the healthcare industry, remains a focal point for investors seeking stability and income in a volatile market. With a market capitalization of $88.65 billion,..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 19.75% Potential Upside with Robust Revenue Growth

Repligen Corporation (NASDAQ: RGEN), a distinguished player in the healthcare sector, particularly within the medical instruments and supplies industry, stands out with its innovative bioprocessing technologies. With a market capitalization..

Ascendis Pharma A/S (ASND) Stock Analysis: 19.6% Potential Upside Amidst Robust Revenue Growth

For investors seeking opportunities in the biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents an intriguing case with its promising growth prospects anchored in innovative healthcare solutions. Headquartered in Hellerup,..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Strong Buy Ratings and 23% Upside Potential

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector specializing in drug manufacturing for neurological, neuroendocrine, and neuropsychiatric disorders, is positioned for significant investor interest. With a current..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 6.35% Dividend Yield Amidst Market Dynamics

Pfizer, Inc. (NYSE: PFE) stands as a titan in the healthcare sector, specifically within the realm of general drug manufacturing. With a robust market capitalization of $155.61 billion, Pfizer continues..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds